Author

Catarina P. Santos

Spanish National Cancer Research CentreORCID 0000-0003-3139-2484Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Catarina P. Santos1 paper

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Francisco X. RealiD· 2 shared Amy Guillaumet-AdkinsiD· 1 shared Andreas SchlattliD· 1 shared Cátia MoutinhoiD· 1 shared Elisabetta MereuiD· 1 shared Giovanni Lo IaconoiD· 1 shared Giulia LunazziiD· 1 shared Gordana Wutz· 1 shared

Activity by Year

2017-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Francisco X. RealORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintMay 7, 2018

matchSCore: Matching Single-Cell Phenotypes Across Tools and Experiments

Elisabetta Mereu, Giovanni Lo Iacono, Amy Guillaumet-Adkins…·Holger Heyn

matchSCore matches cell populations across tools, experiments, and technologies by comparing clustering and marker gene identification accuracy in simulated data and applying it to mouse and human cell atlas projects.

11 citations

𝕏 PostBluesky

Cell BiologybioRxivPreprintApr 8, 2017

Hardwired synthetic lethality within the cohesin complex in human cancer cells

Petra van der Lelij, Simone Lieb, Julian Jude…·Mark Petronczki

This study identifies a synthetic lethal interaction between STAG1 and STAG2 in cancers with STAG2 mutations, suggesting STAG1 as a therapeutic target.

DOI 10.1101/125708

humangenetic perturbation / CRISPR

𝕏 PostBluesky